Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Margarita Pileckyte

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Medicina (Kaunas, Lithuania)|June 10, 2003
[A rare case of differential diagnosis of myopathy]Margarita Pileckyte
Medicina (Kaunas, Lithuania)|June 10, 2003
[Erythema nodosum association with malignant lymphoma]Margarita Pileckyte, Rasa Griniūte
Medicina (Kaunas, Lithuania)|June 10, 2003
[Paraneoplastic rheumatic syndromes]Margarita Pileckyte, Rūta Baliūnaite, Valerija Tamulaitiene
Medicina (Kaunas, Lithuania)|June 24, 2010
Clinical characteristics and long-term outcomes of 35 patients with Wegener's granulomatosis followed up at two rheumatology centers in LithuaniaJolanta Dadoniene, Margarita Pileckyte, Asta Baranauskaite, et al.
Medicina (Kaunas, Lithuania)|March 18, 2010
Severe vancomycin-induced anaphylactic reactionRūta Kupstaite, Asta Baranauskaite, Margarita Pileckyte, et al.
Arthritis and Rheumatism|August 1, 2008
Rho-associated kinases are crucial for myofibroblast differentiation and production of extracellular matrix in scleroderma fibroblastsAlfiya Akhmetshina, Clara Dees, Margarita Pileckyte, et al.
Arthritis Research & Therapy|August 17, 2018
A comparative clinical study of PF-06410293, a candidate adalimumab biosimilar, and adalimumab reference product (Humira®) in the treatment of active rheumatoid arthritisRoy M Fleischmann, Rieke Alten, Margarita Pileckyte, et al.
Circulation|November 26, 2009
Transcription factor fos-related antigen-2 induces progressive peripheral vasculopathy in mice closely resembling human systemic sclerosisBritta Maurer, Nicole Busch, Astrid Jüngel, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 14, 2018
Switching From Reference Adalimumab to SB5 (Adalimumab Biosimilar) in Patients With Rheumatoid Arthritis: Fifty-Two-Week Phase III Randomized Study ResultsMichael E Weinblatt, Asta Baranauskaite, Eva Dokoupilova, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 11, 2008
Dual inhibition of c-abl and PDGF receptor signaling by dasatinib and nilotinib for the treatment of dermal fibrosisAlfiya Akhmetshina, Clara Dees, Margarita Pileckyte, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Medicina (Kaunas, Lithuania)|June 10, 2003
[A rare case of differential diagnosis of myopathy]Margarita Pileckyte
Medicina (Kaunas, Lithuania)|June 10, 2003
[Erythema nodosum association with malignant lymphoma]Margarita Pileckyte, Rasa Griniūte
Medicina (Kaunas, Lithuania)|June 10, 2003
[Paraneoplastic rheumatic syndromes]Margarita Pileckyte, Rūta Baliūnaite, Valerija Tamulaitiene
Medicina (Kaunas, Lithuania)|June 24, 2010
Clinical characteristics and long-term outcomes of 35 patients with Wegener's granulomatosis followed up at two rheumatology centers in LithuaniaJolanta Dadoniene, Margarita Pileckyte, Asta Baranauskaite, et al.
Medicina (Kaunas, Lithuania)|March 18, 2010
Severe vancomycin-induced anaphylactic reactionRūta Kupstaite, Asta Baranauskaite, Margarita Pileckyte, et al.
Arthritis and Rheumatism|August 1, 2008
Rho-associated kinases are crucial for myofibroblast differentiation and production of extracellular matrix in scleroderma fibroblastsAlfiya Akhmetshina, Clara Dees, Margarita Pileckyte, et al.
Arthritis Research & Therapy|August 17, 2018
A comparative clinical study of PF-06410293, a candidate adalimumab biosimilar, and adalimumab reference product (Humira®) in the treatment of active rheumatoid arthritisRoy M Fleischmann, Rieke Alten, Margarita Pileckyte, et al.
Circulation|November 26, 2009
Transcription factor fos-related antigen-2 induces progressive peripheral vasculopathy in mice closely resembling human systemic sclerosisBritta Maurer, Nicole Busch, Astrid Jüngel, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 14, 2018
Switching From Reference Adalimumab to SB5 (Adalimumab Biosimilar) in Patients With Rheumatoid Arthritis: Fifty-Two-Week Phase III Randomized Study ResultsMichael E Weinblatt, Asta Baranauskaite, Eva Dokoupilova, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 11, 2008
Dual inhibition of c-abl and PDGF receptor signaling by dasatinib and nilotinib for the treatment of dermal fibrosisAlfiya Akhmetshina, Clara Dees, Margarita Pileckyte, et al.
Pageof 2